ArticleJournal of medical case reports2025
Refractory high anion gap metabolic acidosis due to chronic paracetamol use: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMetabolic acidosis is a frequent finding in clinical practice, particularly among critically ill patients. While common causes of high anion gap metabolic acidosis, such as diabetic ketoacidosis, renal failure, lactic acidosis, and toxins are easy to diagnose, less typical causes require heightened clinical suspicion. We report an unusual cause of high anion gap metabolic acidosis, which required specific therapeutic measures. CASE PRESENTATION: A 45-year-old Sinhalese female with diabetes presented with severe metabolic acidosis and Kussmaul breathing. Initial treatment for sepsis and renal failure, including intravenous bicarbonate and dialysis, failed to correct the acidosis. Further evaluation revealed chronic therapeutic use of paracetamol and elevated urinary 5-oxoproline levels, which confirmed pyroglutamic acidosis. Her acidosis resolved promptly with N-acetylcysteine therapy and suspension of paracetamol. DISCUSSION: Chronic ingestion of therapeutic doses of paracetamol is an increasingly reported cause of high anion gap metabolic acidosis. This is a distinct entity from acidosis that results from paracetamol toxicity, which is due to liver derangement and lactic acidosis. Paracetamol depletes glutathione and this impacts the gamma glutamyl cycle, causing accumulation of 5-oxyproline/pyruvic acid. Clinicians should be aware of this rare but reversible cause in patients on long-term paracetamol therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.